Alk-SMase acts with phospholipase C to hydrolyse sphingomyelin (SM) to ceramide, inactivate platelet-activating factor (PAF) and reduce the formation of lysophosphatidic acid (LPA); these effects are all associated with the inhibition of colon cancer [1, 2]. Here, ENPP7 is linked to colonic neoplasm.